Idexx Laboratories Company Profile (NASDAQ:IDXX)

About Idexx Laboratories

Idexx Laboratories logoIDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company's segments include Companion Animal Group (CAG), which develops, designs, manufactures and distributes products and performs services for veterinarians and the bioresearch market; Water, which develops, designs, manufactures and distributes a range of products used in the detection of various microbiological parameters in water; Livestock, Poultry and Dairy (LPD), which develops, designs, manufactures and distributes diagnostic tests and related instrumentation, and performs services that are used to manage the health status of livestock and poultry and to expand bovine reproductive productivity, and Other, which develops, designs, manufactures and distributes point-of-care electrolyte and blood gas analyzers and related consumable products for the human medical diagnostics market.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: IDXX
  • CUSIP: 45168D10
Key Metrics:
  • Previous Close: $113.38
  • 50 Day Moving Average: $112.11
  • 200 Day Moving Average: $98.39
  • 52-Week Range: $63.48 - $117.84
  • Trailing P/E Ratio: 50.31
  • Foreward P/E Ratio: 39.51
  • P/E Growth: 3.35
  • Market Cap: $9.94B
  • Outstanding Shares: 89,540,000
  • Beta: 0.41
  • Net Margins: 11.94%
  • Return on Equity: -414.67%
  • Return on Assets: 14.36%
  • Debt-to-Equity Ratio: -70.43%
  • Current Ratio: 1.00%
  • Quick Ratio: 0.78%
Additional Links:
Companies Related to Idexx Laboratories:

Analyst Ratings

Consensus Ratings for Idexx Laboratories (NASDAQ:IDXX) (?)
Ratings Breakdown: 4 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $102.50 (3.91% downside)

Analysts' Ratings History for Idexx Laboratories (NASDAQ:IDXX)
DateFirmActionRatingPrice TargetDetails
10/15/2016Canaccord GenuitySet Price TargetBuy$125.00View Rating Details
9/29/2016Bank of America Corp.Reiterated RatingNeutralView Rating Details
8/16/2016Stifel NicolausBoost Price TargetBuy$120.00 -> $125.00View Rating Details
8/3/2016Northcoast ResearchUpgradeSell -> NeutralView Rating Details
4/13/2016Credit Suisse Group AGBoost Price TargetOutperform$80.00 -> $85.00View Rating Details
4/1/2016CL KingInitiated CoverageNeutralView Rating Details
2/1/2016Piper Jaffray Cos.Reiterated RatingNeutral$73.00 -> $75.00View Rating Details
1/31/2016William BlairReiterated RatingOutperformView Rating Details
8/28/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
7/23/2015Feltl & Co.UpgradeSell -> Hold$61.50 -> $69.50View Rating Details
(Data available from 10/26/2014 forward)


Earnings History for Idexx Laboratories (NASDAQ:IDXX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2016Q316$0.60$448.60 millionN/AView Earnings Details
8/2/2016Q216$0.62$0.74$444.83 million$467.00 millionViewListenView Earnings Details
4/29/2016Q116$0.47$0.51$403.48 million$417.55 millionViewListenView Earnings Details
1/29/2016Q415$0.44$0.48$397.39 million$400.00 millionViewListenView Earnings Details
10/28/2015Q315$0.53$0.54$409.33 million$406.00 millionViewListenView Earnings Details
7/30/2015Q215$0.57$0.60$412.57 million$413.30 millionViewListenView Earnings Details
4/28/2015Q115$0.99$0.98$394.38 million$382.00 millionViewN/AView Earnings Details
1/30/2015Q414$0.80$0.54$373.20 million$352.00 millionViewN/AView Earnings Details
10/24/2014Q314$0.90$1.05$371.80 million$384.00 millionViewListenView Earnings Details
7/25/2014Q214$1.05$1.10$385.20 million$390.00 millionViewN/AView Earnings Details
4/25/2014Q114$0.87$0.89$361.58 million$360.20 millionViewListenView Earnings Details
2/4/2014Q413$0.81$0.82$347.08 million$354.10 millionViewN/AView Earnings Details
10/22/2013Q313$0.83$0.86$339.70 million$338.30 millionViewN/AView Earnings Details
7/23/2013Q2 2013$0.97$0.99$356.80 million$352.60 millionViewN/AView Earnings Details
4/23/2013Q1 2013$0.83$0.81$341.06 million$332.10 millionViewN/AView Earnings Details
1/29/2013Q4 2012$0.71$0.78$325.10 million$319.50 millionViewN/AView Earnings Details
10/19/2012$0.73$0.76ViewN/AView Earnings Details
7/20/2012$0.90$0.91ViewN/AView Earnings Details
4/20/2012$0.71$0.72ViewN/AView Earnings Details
1/27/2012$0.63$0.67ViewN/AView Earnings Details
10/21/2011$0.65$0.66ViewN/AView Earnings Details
7/22/2011$0.72$0.83ViewN/AView Earnings Details
4/21/2011$0.59$0.62ViewN/AView Earnings Details
1/28/2011$0.55$0.62ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Idexx Laboratories (NASDAQ:IDXX)
Current Year EPS Consensus Estimate: $2.36 EPS
Next Year EPS Consensus Estimate: $2.70 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.46$0.47$0.47
Q2 20163$0.62$0.63$0.63
Q3 20163$0.58$0.62$0.60
Q4 20163$0.49$0.54$0.51
Q1 20171$0.58$0.58$0.58
Q2 20171$0.88$0.88$0.88
Q3 20171$0.69$0.69$0.69
Q4 20171$0.55$0.55$0.55
(Data provided by Zacks Investment Research)


Dividend History for Idexx Laboratories (NASDAQ:IDXX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Idexx Laboratories (NASDAQ:IDXX)
Insider Ownership Percentage: 2.79%
Institutional Ownership Percentage: 91.53%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/25/2016Rebecca M HendersonDirectorSell9,924$110.43$1,095,907.32View SEC Filing  
8/15/2016Barry C JohnsonDirectorSell9,924$111.37$1,105,235.88View SEC Filing  
8/8/2016Michael J. Phd WilliamsInsiderSell49,560$108.94$5,399,066.40View SEC Filing  
8/5/2016William T EndDirectorSell5,000$108.50$542,500.00View SEC Filing  
8/4/2016Jonathan W. AyersChairmanSell60,000$107.69$6,461,400.00View SEC Filing  
5/5/2016William T EndDirectorSell4,924$85.87$422,823.88View SEC Filing  
2/24/2016Michael J Phd WilliamsEVPSell2,000$71.93$143,860.00View SEC Filing  
2/9/2016Thomas CraigDirectorSell2,054$69.52$142,794.08View SEC Filing  
2/8/2016Brian P. MckeonCFOSell9,054$69.65$630,611.10View SEC Filing  
11/30/2015Thomas CraigDirectorSell7,000$70.28$491,960.00View SEC Filing  
11/12/2015Rebecca M. HendersonDirectorSell2,300$68.39$157,297.00View SEC Filing  
8/31/2015Thomas CraigDirectorSell800$71.77$57,416.00View SEC Filing  
8/18/2015Michael J. Phd WilliamsEVPSell6,586$78.34$515,947.24View SEC Filing  
8/18/2015Thomas CraigDirectorSell2,900$79.41$230,289.00View SEC Filing  
8/17/2015Jonathan W AyersCEOSell14,799$78.45$1,160,981.55View SEC Filing  
5/18/2015William T EndDirectorSell3,527$134.51$474,416.77View SEC Filing  
3/10/2015William T EndDirectorSell3,500$150.89$528,115.00View SEC Filing  
3/4/2015Johnny D PowersEVPSell6,168$158.49$977,566.32View SEC Filing  
2/17/2015Brian P MckeonCFOSell5,000$156.99$784,950.00View SEC Filing  
2/12/2015Jonathan W AyersCEOSell58,245$155.45$9,054,185.25View SEC Filing  
2/5/2015Rebecca M HendersonDirectorSell2,934$156.27$458,496.18View SEC Filing  
2/4/2015Thomas CraigDirectorSell2,200$157.02$345,444.00View SEC Filing  
1/14/2015Jonathan W AyersCEOSell28,512$157.68$4,495,772.16View SEC Filing  
12/3/2014Jonathan W AyersCEOSell29,000$148.49$4,306,210.00View SEC Filing  
11/13/2014Thomas CraigDirectorSell5,000$152.45$762,250.00View SEC Filing  
11/5/2014Jonathan W AyersCEOSell29,000$143.45$4,160,050.00View SEC Filing  
11/4/2014Johnny D PowersEVPSell1,292$142.70$184,368.40View SEC Filing  
8/13/2014M Anne SzostakDirectorBuy2,000$127.03$254,060.00View SEC Filing  
2/20/2014M Anne SzostakDirectorBuy2,000$126.71$253,420.00View SEC Filing  
2/19/2014Thomas CraigDirectorSell4,800$125.42$602,016.00View SEC Filing  
2/3/2014Jonathan AyersCEOSell81,294$112.46$9,142,323.24View SEC Filing  
11/26/2013Jonathan AyersCEOSell78,178$105.29$8,231,361.62View SEC Filing  
11/22/2013Sophie VandebroekDirectorBuy1,000$107.84$107,840.00View SEC Filing  
11/13/2013Jonathan AyersCEOSell78,178$106.36$8,315,012.08View SEC Filing  
11/4/2013M Anne SzostakDirectorBuy1,000$108.24$108,240.00View SEC Filing  
11/4/2013Michael Phd WilliamsEVPSell6,020$108.19$651,303.80View SEC Filing  
10/31/2013William T EndDirectorSell2,500$108.32$270,800.00View SEC Filing  
10/25/2013Jonathan W AyersCEOSell78,178$104.36$8,158,656.08View SEC Filing  
9/13/2013Johnny PowersEVPSell13,128$96.59$1,268,033.52View SEC Filing  
9/5/2013Michael J Phd WilliamsEVPSell5,162$95.58$493,383.96View SEC Filing  
5/9/2013Ali NaquiVPSell12,961$87.00$1,127,607.00View SEC Filing  
2/4/2013Merilee RainesCFOSell175,929$94.25$16,581,308.25View SEC Filing  
11/13/2012Jonathan W AyersCEOSell15,000$89.92$1,348,800.00View SEC Filing  
9/5/2012Johnny D PowersEVPSell4,000$97.12$388,480.00View SEC Filing  
8/8/2012Merilee RainesCFOSell7,726$88.84$686,377.84View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Idexx Laboratories (NASDAQ:IDXX)
News IconNewsmaking Penny Stock: Investors Checking Out IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Duncan Research (NASDAQ:IDXX) - October 26 at 8:46 AM
News IconColumbus Circle Investors invests in Idexx Laboratories Inc. (IDXX) Shares - DailyQuint (NASDAQ:IDXX) - October 26 at 8:46 AM logoIDEXX Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : IDXX-US : October 25, 2016 (NASDAQ:IDXX) - October 25 at 10:32 AM
News IconIDEXX Laboratories, Inc. (NASDAQ: IDXX) – Is this large market cap ... - The Daily Leicester (NASDAQ:IDXX) - October 22 at 9:43 AM logoBaron Funds Comments on IDEXX Laboratories Inc. (NASDAQ:IDXX) - October 21 at 5:38 PM logo56.1% Return Seen to Date on SmarTrend Idexx Laboratories Call (IDXX) (NASDAQ:IDXX) - October 21 at 8:48 AM logoIDEXX Laboratories, Inc. (NASDAQ:IDXX) Files An 8-K - Market Exclusive (NASDAQ:IDXX) - October 20 at 5:40 PM logoIDEXX Laboratories Elects Lawrence D. Kingsley to Board of Directors (NASDAQ:IDXX) - October 19 at 5:55 PM logoIDEXX LABORATORIES INC /DE Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex (NASDAQ:IDXX) - October 19 at 5:55 PM logoEPS Forecast Of IDEXX Laboratories, Inc. (NASDAQ:IDXX) At $0.59 - (NASDAQ:IDXX) - October 18 at 5:31 PM
News IconSteering Attention Towards Earnings; Analysts Weigh in on IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock - CSZ News (NASDAQ:IDXX) - October 18 at 5:31 PM
News IconStock's Earnings in Focus: IDEXX Laboratories, Inc. (NASDAQ:IDXX), PETVIVO HLDGS (OTCMKTS:PETV), Aratana ... - The Independent Republic (NASDAQ:IDXX) - October 18 at 5:31 PM
News IconPrudential Financial Inc. invests in 690 by purchasing Idexx ... - DailyQuint (NASDAQ:IDXX) - October 15 at 10:19 AM
News IconHigh Market Cap Stock of the Day – IDEXX Laboratories, Inc. (NASDAQ:IDXX) (NASDAQ:IDXX) - October 14 at 8:42 AM logoUptrend Call Working As Idexx Laboratories Stock Rises 54.3% (IDXX) (NASDAQ:IDXX) - October 13 at 5:35 PM logoIDEXX Laboratories : to Release 2016 Third Quarter Financial Results (NASDAQ:IDXX) - October 13 at 8:49 AM
News IconIn it for the Long Haul: Update on IDEXX Laboratories, Inc. (NASDAQ:IDXX) - CSZ News (NASDAQ:IDXX) - October 12 at 5:35 PM logoIDEXX Laboratories to Release 2016 Third Quarter Financial Results (NASDAQ:IDXX) - October 11 at 5:46 PM logoBaron Funds Comments on IDEXX Laboratories (NASDAQ:IDXX) - October 11 at 5:46 PM logoIDEXX Laboratories, Inc. (NASDAQ:IDXX) EPS Forecast At $0.59 - (NASDAQ:IDXX) - October 10 at 5:19 PM logoIDEXX Laboratories, Inc. (IDXX) Sees New 52-Week High - Finance Daily (NASDAQ:IDXX) - October 8 at 5:16 PM
News IconTrader's Buzzer: PETVIVO HLDGS INC COM USD0.001 (OTCMKTS ... - The Independent Republic (NASDAQ:IDXX) - October 7 at 10:33 AM
News IconTrader's Buzzer: PETVIVO HLDGS INC COM USD0.001 (OTCMKTS:PETV), IDEXX Laboratories, Inc. (NASDAQ:IDXX ... - The Independent Republic (NASDAQ:IDXX) - October 7 at 10:33 AM
News IconTop Gainers of the Day: IDEXX Laboratories, Inc. (NASDAQ:IDXX) from Diagnostic Substances (NASDAQ:IDXX) - October 6 at 10:56 AM logoNoteworthy ETF Outflows: MDY, IDXX, WWAV, SNPS - Nasdaq (NASDAQ:IDXX) - October 5 at 5:31 PM
News IconBroker Roundup For IDEXX Laboratories, Inc. (NASDAQ:IDXX) - The De Soto Edge (NASDAQ:IDXX) - October 4 at 10:20 AM logoIDEXX Laboratories, Inc. (NASDAQ:IDXX) Mean Rating At $2.25 - (NASDAQ:IDXX) - October 4 at 10:20 AM logoWatch These Stocks for a Breakout Move (CSCO, CRH) (NASDAQ:IDXX) - October 3 at 10:10 AM
News IconUpgrades And Downgrades For IDEXX Laboratories, Inc. (NASDAQ ... - NewsDen (NASDAQ:IDXX) - October 2 at 9:54 AM
News IconIDEXX Laboratories, Inc. (NASDAQ:IDXX) – Broker Update - NewsDen (NASDAQ:IDXX) - October 1 at 10:56 AM logoVarian Medical Unveils HyperArc HDRT for Cancer Treatment - Yahoo Finance (NASDAQ:IDXX) - September 30 at 5:48 PM logoBank of America Starts Coverage on IDEXX Laboratories, Inc. (IDXX) With A Rating Of "Neutral" - Finance Daily (NASDAQ:IDXX) - September 29 at 10:39 AM logoIdexx Laboratories Shares Up 56.9% Since SmarTrend's Buy Recommendation (IDXX) (NASDAQ:IDXX) - September 28 at 5:24 PM logoNotable ETF Inflow Detected - MDY, IDXX, WWAV, COO - Nasdaq (NASDAQ:IDXX) - September 27 at 5:34 PM logoNotable ETF Inflow Detected - MDY, IDXX, WWAV, COO (NASDAQ:IDXX) - September 27 at 5:34 PM logoJim Cramer Gives His Opinion On Starbucks, IDEXX Laboratories And VCA - Benzinga (NASDAQ:IDXX) - September 27 at 5:34 PM logoIDEXX Laboratories, Inc. (NASDAQ:IDXX): Price Target Stands At $100.75 - (NASDAQ:IDXX) - September 26 at 5:41 PM logoFirst Week of IDXX November 18th Options Trading (NASDAQ:IDXX) - September 23 at 5:13 PM logoBaron Asset Fund Position In IDEXX Laboratories, Inc (NASDAQ:IDXX) - September 23 at 5:13 PM logoWhat's Going on at Idexx Laboratories? (NASDAQ:IDXX) - September 21 at 4:39 PM logoIdexx Laboratories Shares Up 55.8% Since SmarTrend's Buy Recommendation (IDXX) (NASDAQ:IDXX) - September 21 at 9:46 AM logoMDY, WWAV, IDXX, COO: Large Outflows Detected at ETF - Nasdaq (NASDAQ:IDXX) - September 20 at 10:42 AM
News IconStock Update: Estimates & Target in Focus for IDEXX Laboratories ... - Frisco Fastball (NASDAQ:IDXX) - September 20 at 10:42 AM logoMDY, WWAV, IDXX, COO: Large Outflows Detected at ETF (NASDAQ:IDXX) - September 19 at 5:38 PM logoIDEXX Laboratories, Inc. (NASDAQ:IDXX) Accounts Payable Is $50.085 - (NASDAQ:IDXX) - September 17 at 5:16 PM
News IconHow has IDEXX Laboratories, Inc.:(NASDAQ:IDXX) performed recently? - The Daily Leicester (NASDAQ:IDXX) - September 17 at 5:16 PM
News IconA look at a High Market Cap Stock: IDEXX Laboratories, Inc., IDXX ... - The Daily Leicester (NASDAQ:IDXX) - September 14 at 5:41 PM logoShares of IDXX Up 52.6% Since Uptrend Call on Shares (NASDAQ:IDXX) - September 14 at 9:48 AM logoResearch Analysts Set IDEXX Laboratories, Inc. (NASDAQ:IDXX)’s Price Target At $100.75 (NASDAQ:IDXX) - September 13 at 10:24 AM logoAcadia & Ochsner Form Partnership, Announce New Facility (NASDAQ:IDXX) - September 13 at 10:24 AM


Idexx Laboratories (NASDAQ:IDXX) Chart for Wednesday, October, 26, 2016

Last Updated on 10/26/2016 by Staff